04
2022
PolyPeptide
CEO
Raymond
De Vré
Head IR
Michael
Stäheli
ZKB Analyst: Daniel Buchta
Group meeting, One-on-one, Small group meeting
PolyPeptide Group AG operates as a biotechnology company. The Company focuses on producing proprietary and generic GMP grade peptides for the pharmaceutical and biotechnology industry. PolyPeptide Group serves customers worldwide.